Piper Sandler: 'We Remain Bullish on Edgewise Therapeutics (EWTX) and See Compelling Buying Opportunity'
Tweet Send to a Friend
Piper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $51.00 price target on Edgewise Therapeutics (NASDAQ: EWTX).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
